Stay updated on Primary Oral Insulin Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Primary Oral Insulin Immunotherapy Clinical Trial page.

Latest updates to the Primary Oral Insulin Immunotherapy Clinical Trial page
- Check5 days agoChange DetectedAn NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the study page’s 403 Forbidden error.SummaryDifference1%

- Check12 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check19 days agoChange DetectedThe revision label in the footer of the ClinicalTrials.gov 403 Forbidden page changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now displays a 403 Forbidden error page with a minimal header and navigation, replacing the previous study record content. The additions show the 403 text, a basic header, a Home link, and a revision notice.SummaryDifference18%

- Check61 days agoChange DetectedDisplayed revision updated from v3.6.5 to v3.6.6, indicating a minor update to the page's metadata rather than substantive study details.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page now includes expanded metadata such as MeSH terms, affiliations, collaborators, and publications, along with study record dates and related navigation items. These additions provide richer contextual and indexing information without altering the central study details.SummaryDifference49%

Stay in the know with updates to Primary Oral Insulin Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Primary Oral Insulin Immunotherapy Clinical Trial page.